| Symbol |
Name |
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCD1
|
ATP-binding cassette, sub-family D (ALD), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ACTA1
|
actin, alpha 1, skeletal muscle
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM22
|
ADAM metallopeptidase domain 22
|
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
AMH
|
anti-Mullerian hormone
|
|
AMHR2
|
anti-Mullerian hormone receptor, type II
|
|
ANKRD11
|
ankyrin repeat domain 11
|
|
APC
|
adenomatous polyposis coli
|
|
AQP10
|
aquaporin 10
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ARX
|
aristaless related homeobox
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ASNA1
|
arsA arsenite transporter, ATP-binding, homolog 1 (bacterial)
|
|
AURKA
|
aurora kinase A
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
CA2
|
carbonic anhydrase II
|
|
CA9
|
carbonic anhydrase IX
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CCAR1
|
cell division cycle and apoptosis regulator 1
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCND1
|
cyclin D1
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDC42
|
cell division cycle 42
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHGA
|
chromogranin A
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CLDN16
|
claudin 16
|
|
CLDN2
|
claudin 2
|
|
CLDN3
|
claudin 3
|
|
CLDN4
|
claudin 4
|
|
CLDN5
|
claudin 5
|
|
CLDN7
|
claudin 7
|
|
CORT
|
cortistatin
|
|
CRH
|
corticotropin releasing hormone
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CUEDC2
|
CUE domain containing 2
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
DENND1A
|
DENN/MADD domain containing 1A
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DYX1C1
|
dyslexia susceptibility 1 candidate 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2
|
|
EGLN3
|
egl-9 family hypoxia-inducible factor 3
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRG
|
estrogen-related receptor gamma
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
FGF19
|
fibroblast growth factor 19
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FKBPL
|
FK506 binding protein like
|
|
FNDC5
|
fibronectin type III domain containing 5
|
|
FOXA1
|
forkhead box A1
|
|
FOXA2
|
forkhead box A2
|
|
FTO
|
fat mass and obesity associated
|
|
GABARAP
|
GABA(A) receptor-associated protein
|
|
GABARAPL1
|
GABA(A) receptor-associated protein like 1
|
|
GCG
|
glucagon
|
|
GH1
|
growth hormone 1
|
|
GHRH
|
growth hormone releasing hormone
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GNAS
|
GNAS complex locus
|
|
GNRHR2
|
gonadotropin-releasing hormone (type 2) receptor 2, pseudogene
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPHA2
|
glycoprotein hormone alpha 2
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC11
|
histone deacetylase 11
|
|
HDAC6
|
histone deacetylase 6
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HNF1B
|
HNF1 homeobox B
|
|
HOTAIR
|
HOX transcript antisense RNA
|
|
HOXB13
|
homeobox B13
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
IAPP
|
islet amyloid polypeptide
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFALS
|
insulin-like growth factor binding protein, acid labile subunit
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IL15
|
interleukin 15
|
|
IL6
|
interleukin 6
|
|
INHBA
|
inhibin, beta A
|
|
INS
|
insulin
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
INSM1
|
insulinoma-associated 1
|
|
INSR
|
insulin receptor
|
|
ISL1
|
ISL LIM homeobox 1
|
|
JAK2
|
Janus kinase 2
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KL
|
klotho
|
|
KLB
|
klotho beta
|
|
KRT19
|
keratin 19, type I
|
|
LAMC2
|
laminin, gamma 2
|
|
LCN2
|
lipocalin 2
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LMTK3
|
lemur tyrosine kinase 3
|
|
LTF
|
lactotransferrin
|
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1
|
|
MAOA
|
monoamine oxidase A
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBOAT4
|
membrane bound O-acyltransferase domain containing 4
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC4R
|
melanocortin 4 receptor
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MIR195
|
microRNA 195
|
|
MIR206
|
microRNA 206
|
|
MIR7-1
|
microRNA 7-1
|
|
MIR7-2
|
microRNA 7-2
|
|
MIR7-3
|
microRNA 7-3
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLN
|
motilin
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MTA1
|
metastasis associated 1
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MYBBP1A
|
MYB binding protein (P160) 1a
|
|
MYO15A
|
myosin XVA
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NEUROD1
|
neuronal differentiation 1
|
|
NEUROG3
|
neurogenin 3
|
|
NKX2-2
|
NK2 homeobox 2
|
|
NPY
|
neuropeptide Y
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRG4
|
neuregulin 4
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NTS
|
neurotensin
|
|
ONECUT1
|
one cut homeobox 1
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PALLD
|
palladin, cytoskeletal associated protein
|
|
PAX8
|
paired box 8
|
|
PCSK1
|
proprotein convertase subtilisin/kexin type 1
|
|
PCSK2
|
proprotein convertase subtilisin/kexin type 2
|
|
PCSK5
|
proprotein convertase subtilisin/kexin type 5
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PDYN
|
prodynorphin
|
|
PENK
|
proenkephalin
|
|
PGR
|
progesterone receptor
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PKD3
|
polycystic kidney disease 3 (autosomal dominant)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPY
|
pancreatic polypeptide
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PROK1
|
prokineticin 1
|
|
PROM1
|
prominin 1
|
|
PRPH2
|
peripherin 2 (retinal degeneration, slow)
|
|
PSAP
|
prosaposin
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPRO
|
protein tyrosine phosphatase, receptor type, O
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PTTG1IP
|
pituitary tumor-transforming 1 interacting protein
|
|
PTX3
|
pentraxin 3, long
|
|
PYY
|
peptide YY
|
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASL10B
|
RAS-like, family 10, member B
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region
|
|
REG3A
|
regenerating islet-derived 3 alpha
|
|
RET
|
ret proto-oncogene
|
|
RFX6
|
regulatory factor X, 6
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RLN2
|
relaxin 2
|
|
RPA2
|
replication protein A2, 32kDa
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPS6KB2
|
ribosomal protein S6 kinase, 70kDa, polypeptide 2
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
RXFP2
|
relaxin/insulin-like family peptide receptor 2
|
|
SCG2
|
secretogranin II
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SEPT5
|
septin 5
|
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SHBG
|
sex hormone-binding globulin
|
|
SIAH2
|
siah E3 ubiquitin protein ligase 2
|
|
SIM1
|
single-minded family bHLH transcription factor 1
|
|
SLC18A1
|
solute carrier family 18 (vesicular monoamine transporter), member 1
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SPHK2
|
sphingosine kinase 2
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SSTR1
|
somatostatin receptor 1
|
|
SSTR2
|
somatostatin receptor 2
|
|
SSTR3
|
somatostatin receptor 3
|
|
SSTR4
|
somatostatin receptor 4
|
|
SSTR5
|
somatostatin receptor 5
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
SYP
|
synaptophysin
|
|
TAB2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2
|
|
TAC1
|
tachykinin, precursor 1
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THADA
|
thyroid adenoma associated
|
|
THBS1
|
thrombospondin 1
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TMSB4X
|
thymosin beta 4, X-linked
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPS1
|
trichorhinophalangeal syndrome I
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
VCP
|
valosin containing protein
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VGF
|
VGF nerve growth factor inducible
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
XBP1
|
X-box binding protein 1
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
ZNF367
|
zinc finger protein 367
|
